Routine use of progesterone does not prevent miscarriage.

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Clinical Trials

Background:

• Early pregnancy bleeding is a common concern for many women.
• The use of progesterone has been suggested as a potential treatment to prevent miscarriage.
• Evidence supporting routine progesterone use for threatened miscarriage was previously limited.

Purpose of the Study:

• To investigate the efficacy of progesterone in preventing miscarriage in women with early pregnancy bleeding.
• To determine if routine progesterone administration improves live birth rates in this patient group.

Main Methods:

• A large-scale, randomized, placebo-controlled trial was conducted.
• Participants received either progesterone or a placebo.
• Outcomes included live birth rates and miscarriage rates.

Main Results:

• There was no significant difference in live birth rates between the progesterone group and the placebo group.
• The routine administration of progesterone did not reduce the rate of miscarriage.
• No significant adverse effects were reported for either treatment group.

Conclusions:

• Routine progesterone treatment is not effective in preventing miscarriage in women with early pregnancy bleeding.
• The findings do not support the use of progesterone for threatened miscarriage.
• Further research may be needed to identify effective interventions for early pregnancy loss.